Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesGene expression signatures, clinicopathological features, and individualized therapy in breast cancer
JAMA, 04/03/08
Acharya CR et al. - Incorporation of gene expression signatures into clinical risk stratification can refine prognosis
Methods- Retrospective study of early stage breast carcinoma candidates for adjuvant chemotherapy
- Review of microarray data for 964 clinically annotated breast tumor samples (573 in initial set; 391 in validation cohort)
- Relapse risk scores based on respective clinicopathologic features
- Main outcome measures: gene expression signatures and clinicopathological variables in early stage breast cancer to determine a refined estimation of relapse-free survival and sensitivity to chemotherapy
- In initial 573 pts, prognostically significant clusters as patterns of oncogenic pathway activation and tumor biology/microenvironment states were identified within the low-, intermediate-, and high-risk model cohorts
- Multivariate analyses confirmed independent prognostic value of genomic clusters
- Related, not identical, clusters in the independent validation cohort established reproducibility and validity of pathway deregulation patterns in predicting relapse risk
- The prognostic clinicogenomic clusters showed unique sensitivity patterns to commonly used cytotoxic therapies
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 74%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
Breast Cancer Research and Treatment, 10/27/09
Relevance Score: 72%
Underweight and breast cancer recurrence and death: A report from the Korean breast cancer society
Journal of Clinical Oncology, 10/08/09
Relevance Score: 72%
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study
Cancer Epidemiology, Biomarkers & Prevention, 10/01/09
Relevance Score: 72%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Evidence of measles virus antigens and RNA in endometrial cancer
European Journal of Obstetrics & Gynecology and Reproductive Biology , 11/20/09
An efficient protocol for the detection of chromosomal abnormalities in spontaneous miscarriages or foetal deaths
European Journal of Obstetrics & Gynecology and Reproductive Biology , 11/20/09
Angiogenic dysfunction in molar pregnancy
American Journal of Obstetrics and Gynecology, 11/19/09
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Clinical Cancer Research, 11/20/09
One hundred cases of abdominal-based free flaps in breast reconstruction. The impact of preoperative computed tomographic angiography
Journal of Plastic, Reconstructive & Aesthetic Surgery, 11/20/09
Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: A debated clinical issue
Gynecological Endocrinology, 11/20/09
Sponsor
Article Search
Sponsor